Detalles de la búsqueda
1.
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).
Oncologist
; 29(3): e330-e336, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950903
2.
Adjuvant and post-recurrent treatment patterns in patients with resectable gastric cancer in japan: a retrospective database cohort study.
Gastric Cancer
; 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38689045
3.
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.
Int J Clin Oncol
; 29(6): 801-812, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589679
4.
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
BMC Cancer
; 23(1): 726, 2023 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37543568
5.
Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancer.
Future Oncol
; 19(23): 1593-1600, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584156
6.
Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807.
Esophagus
; 20(2): 272-280, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36427158
7.
Enhanced phosphorylation of c-Jun by cisplatin treatment as a potential predictive biomarker for cisplatin response in combination with patient-derived tumor organoids.
Lab Invest
; 102(12): 1355-1366, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35922477
8.
Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.
Cancer Sci
; 113(3): 1018-1027, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34962019
9.
Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013.
Jpn J Clin Oncol
; 52(1): 14-23, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34668562
10.
A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.
Jpn J Clin Oncol
; 52(12): 1416-1422, 2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047806
11.
Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study.
Esophagus
; 19(3): 444-451, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050435
12.
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Gastric Cancer
; 24(2): 467-476, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33136231
13.
Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer.
Jpn J Clin Oncol
; 51(6): 879-885, 2021 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33561262
14.
Time-dependent discrepancies between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevacizumab: a post hoc analysis (WJOG4407GSS2).
Support Care Cancer
; 29(7): 3715-3723, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33200233
15.
Influence of preoperative chemotherapy-induced leukopenia on survival in patients with esophageal squamous cell carcinoma: exploratory analysis of JCOG9907.
Esophagus
; 18(1): 41-48, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514753
16.
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07).
Esophagus
; 18(4): 835-843, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33993388
17.
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(8): 1045-1056, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682457
18.
Long-term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer.
Cancer Sci
; 111(5): 1676-1684, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32160365
19.
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
Ann Surg Oncol
; 27(2): 460-467, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31376034
20.
Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
BMC Cancer
; 20(1): 548, 2020 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32532230